Court Dismisses Therapeutics Developer’s Attempt To Force DEA Action on Registration Applications

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Court Dismisses Therapeutics Developer’s Attempt To Force DEA Action on Registration Applications

Dennis Tosh

November 29, 2022 at 10:49:12 ET

A federal district court has dismissed an attempt by a developer of cannabinoid therapeutics to force the DEA to make decisions on the company’s registration applications, holding that the firm had brought its suit in the wrong court (MMJ International Holdings Corp. v. Garland, No. 1:22-cv-00152 (D.R.I. Nov. 10, 2022)). Westerly, Rhode Island-based MMJ International Holdings Corp.... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Court Dismisses Therapeutics Developer’s Attempt To Force DEA Action on Registration Applications

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT